Evidence map›Paper›PMID 27885248›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2016

Rs3842530 Polymorphism in MicroRNA-205 Host Gene in Lung and Breast Cancer Patients.

Fan Zou, Jizhu Li, Xiaohua Jie, Xiong Peng, Ruiqi Fan, Mengmeng Wang, Jiangjie Wang, Zhuoqi Liu, Hua Li, Huan Deng and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Predictive Value of Circulating Tumor Cells for Evaluating Short- and Long-Term Efficacy of Chemotherapy for Breast Cancer.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Fan ZouThe Second Clinical Medical College, School of Medicine, Nanchang University, Nanchang, Jiangxi, China (mainland).
Jizhu LiThe Second Clinic Medical College, School of Medicine, Nanchang University, Nanchang, Jiangxi, China (mainland).
Xiaohua JieThe Second Clinic Medical College, School of Medicine, Nanchang University, Nanchang, Jiangxi, China (mainland).
Xiong PengThe Second Clinic Medical College, School of Medicine, Nanchang University, Nanchang, Jiangxi, China (mainland).
Ruiqi FanDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Nanchang University, Nanchang, Jiangxi, China (mainland).
Mengmeng WangDepartment of Pathology, The Fourth Affiliated Hospital, Nanchang University, Nanchang, Jiangxi, China (mainland).
Jiangjie WangDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Nanchang University, Nanchang, Jiangxi, China (mainland).
Zhuoqi LiuDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Nanchang University, Nanchang, Jiangxi, China (mainland).
Hua LiDepartment of Biochemistry and Molecular Biology, Medical Experimental Teaching Center, Nanchang University, Nanchang, Jiangxi, China (mainland).
Huan DengDepartment of Pathology, The Fourth Affiliated Hospital, Nanchang University, Nanchang, Jiangxi, China (mainland).
Xiaohong YangDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Nanchang University, Nanchang, Jiangxi, China (mainland).
Daya LuoDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Nanchang University, Nanchang, Jiangxi, China (mainland).
Nanchang University · CNSecond Affiliated Hospital of Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND The expression of miR-205 is closely related to the occurrence, development, and prognosis of lung cancer and breast cancer. However, studies show that it plays opposite roles in different tumor types. Because the expression and regulation of miR-205 are primarily confined to epigenetic areas, whether genetic variation of miR-205 is related to the occurrence or to the development of tumors has not been reported. The aim of this study was to screen genetic variation of miR-205 gene and to investigate its association with the risk and development of lung and breast cancer. MATERIAL AND METHODS Genomic DNA was extracted from cultured tumor cell lines and formalin-fixed and paraffin-embedded lung and breast tissue samples. Bisulfite Clone Sequencing (BCS) and qRT-PCR were employed to detect the DNA methylation status and gene expression of the miR-205 gene, respectively. Genetic variation of miR-205 and miR-205HG were genotyped with PCR-sequencing method. Immunohistochemical analysis for ER, PR, and HER2 was performed on breast tissue samples. RESULTS These results indicate that the functional association of rs3842530 in miR-205HG and lung cancer might provide a possible explanation for the tissue-dependent function of miR-205 in different tumors. CONCLUSIONS These results indicate that the functional association of rs3842530 in miR-205HG and lung cancer might provide a possible explanation for the tissue-dependent function of miR-205 in different tumors.

Indexed as

Breast NeoplasmsCell Line, TumorDNA MethylationFemaleGene Expression Regulation, NeoplasticGenetic VariationHumansLung NeoplasmsMCF-7 CellsMicroRNAsPolymorphism, Single NucleotidePrognosisPromoter Regions, GeneticRisk FactorsMicroRNAsMIR205, humanBreast Neoplasms, MaleLung NeoplasmsMicroRNAsPolymorphism, Single Nucleotide

Identifiers

PMID27885248
PMCPMC5136367
OpenAlexW2554435774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.